NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
2.020
-0.180 (-8.18%)
At close: Jun 18, 2026, 4:00 PM EDT
2.120
+0.100 (4.95%)
After-hours: Jun 18, 2026, 5:23 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $7.3 million as of June 18, 2026. Its market cap has decreased by -45.02% in one year.
Market Cap
7.30M
Enterprise Value
-17.53M
1-Year Change
-45.02%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $7.30M, a decrease of -98.33%. That is a compound annual growth rate of -43.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 7.30M | -85.33% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NuCana | 7.95M |
| Curanex Pharmaceuticals | 7.94M |
| HCW Biologics | 7.81M |
| PharmaCyte Biotech | 7.71M |
| Bolt Biotherapeutics | 7.67M |
| Immuron | 7.62M |
| Imunon | 7.25M |
| Ernexa Therapeutics | 7.23M |